Sunday, March 16, 2008

7:30 am–9:30 amInnovations in Imaging (PL)Ballroom AB

Coordinator: Reed A. Omary, MD, MS, FSIR

This session will focus on the latest innovations inimaging technology relevant to the practice of IR.State-of-the art advances in fluoroscopy ultra-sound, computed tomography, and magnetic res-onance imaging will be presented and new clinicalcapabilities resulting from these advances will beexplored. Topics will include: flat panel CT, vol-ume ultrasound imaging, fusion CT/ultrasound,256 MDCT and high field strength MR. Options forimproved guidance and post-processing associatedwith these systems will also be presented.

Objectives—At the end of this session, thelearner should be able to:

1. Describe the basic design characteristics of flatpanel fluoroscopy

2. Explain the functional capabilities of flat panelCT and rotational angiography

3. Summarize design advantages and disadvan-tages of dual source CT

4. Cite potential benefits of volume ultrasound andcontrast-enhanced ultrasound in IR

5. Discuss the potential benefits of high fieldstrength MR for IR applications

7:30 amIntroductionReed A. Omary, MD, MS, FSIR

7:35 amC-arm Angiographic CTMichael J. Wallace, MD, FSIR

7:45 amNavigational TechniquesStephen B. Solomon, MD

7:55 amMulti-detector CT-64 and beyondKlaus D. Hagspiel, MD

8:05 amDual source CTKlaus D. Hagspiel, MD

8:15 amHigh Field MRINeil Rofsky, MD

8:25 amUltra-Fast MRI TechniquesJames Carr, MD

8:35 amInterventional MRIAravind Arepally, MD, FSIR

8:45 am3D and contrast enhanced ultrasoundSteven C. Rose, MD, FSIR

8:55 amHybrid ImagingBradford Johns Wood, MD

9:05 amRoboticsElliot McVeigh, PhD

9:15 amCellular DeliveryJeff W.M. Bulte, PhD

9:25 amFinal Questions

10:00 am–12:00 pmOncologic Interventions: Liver (CC)Ballroom C

Coordinator: William S. Rilling, MD, FSIR

This categorical course is the first course in theNew Developments in Oncologic Interventions se-ries. The focus of this course is on the modernmanagement of primary and metastatic liver can-cer. Presentations will include the evolution andrelative roles of chemoembolization, Y90 radioem-bolization, and percutaneous tumor ablation strat-egies. Recent important developments in systemictherapy and surgical therapy for liver cancer will bereviewed. Emphasis will be placed on publishedoutcomes, evolving treatment algorithms, andmethods for monitoring treatment.

Objectives—At the end of the session, thelearner should be able to:

1. List new developments in transarterial therapyfor liver cancer.

2. Summarize recent advances in systemic and sur-gical therapy for liver cancer.

3. Explain optimal patient selection for ablation ofliver cancer.

4. Describe optimal methods for evaluating re-sponse following image-guided therapy for livercancer.

10:00 amThe Continuing Evolution of Chemoembolization:New Developments and What’s NextJeff H. Geschwind, MD, FSIR

P4

10:15 amY90 Radioembolization: Ready for Prime Time?Riad Salem, MD, MBA, FSIR

10:30 amRecent Advances in Systemic Therapy forPrimary and Metastic Liver CancerTBA

10:45 amAdvances in Surgical Approaches to Liver CancerTBA

11:00 amUpdates on Percutaneous Ablation for HCC andMetastases: New Data and New ApproachesStephen B. Solomon, MD

11:15 amDebate: The Future of Transarterial Therapy forLiver Cancer (TACE is and will remain thestandard, Y90 will eclipse TACE for manydiagnoses)William S. Rilling, MD, FSIR, Riad Salem, MD,MBA, FSIR

11:30 amRational Approaches to Assessing Response andProblem Solving with ImagingDaniel B. Brown, MD

11:45 amPanel Discussion—Therapeutic Algorithms

10:00 am–12:00 pmCase-based Review: Vascular Diagnosis(CC)Ballroom AB

Coordinator: Albert A. Nemcek Jr., MD, FSIR

This year at the Annual Meeting we will initiate aCase-based Review (CBR) series of eight topic-oriented categorical courses. These 2-hour sessionswill cover a broad range of material from VascularDiagnosis to Venous and Arterial Vascular Inter-ventions. In each session, three or four expertfaculty will present three or four cases each (for atotal of 10-12 unknowns) that illustrate the fullrange of interventions in that topic area. Facultywill present cases that challenge the diagnosticacumen or technical and medical knowledge of thelearner. A handout will be prepared for eachcourse that summarizes the important learningpoints of each case and provides references forfurther reading.

Based on the specific topic, at the end of thesession the learner should be able to:

1. Identify key diagnostic imaging findings of se-lected vascular pathologic conditions

2. List appropriate patient selection factors for ar-terial and venous vascular interventions

3 Describe expected complications of vascularand non-vascular interventions

4. Illustrate simple and complex treatment strate-gies for arterial and venous diseases

5. Relate key technical aspects of vascular andnon-vascular interventional procedures

10:00 amCases 1-3Albert A. Nemcek, Jr., MD, FSIR

10:30 amCases 4-6Brian Funaki, MD

11:00 amCases 7-9Charles E. Ray Jr., MD, FSIR

11:30 amCases 10-12Mark L. Montgomery, MD

10:00 am–12:00 pmAdvances in Clinical Care: Coagulation andHemostasis (CC)Room: 207B

Coordinator: Robert K. Kerlan, Jr., MD, FSIR & Wael A.Saad, MD

This course will provide registrants with a reviewof current information on the pathophysiology ofcoagulation and its pharmacologic regulation withan emphasis on applications relevant to interven-tional radiology practice.

Objectives—At the end of the session thelearner should be able to:

1. Describe the mechanism of action of new anti-coagulation agents

2. Discuss medications in common use that affectanticoagulation status

3. Classify pharmacologic agents available for re-versal of coagulopathy

4. Describe topical agents for local control ofbleeding

10:00 amCoagulation Tests and Interventional Radiology:Do we need coags on this patient?Raymond H. Thonton, MD

10:15 amHemostasis: How can I get this tunneled line tostop bleeding?Matthew S. Johnson, MD, FSIR

SUNDAY

P5

10:30 amHeparin Allergy: How to recognize and how tomanageConstantino S. Pena, MD

10:45 amPlatelets: Friend and FoeLawrence ‘Rusty’ Hofmann, MD

11:00 amFibrinolytic Agents: Does it matter which one youuse?Charles P. Semba, MD, FSIR

11:15 amHypercoagulable States and InterventionalRadiologyKarim Valji, MD, FSIR

11:30 amProblem Case Consultation—What Should I DoNow?Robert K. Kerlan, Jr., MD, FSIR, Wael A. Saad, MD

1:30 pm–3:30 pmVenous Insufficiency: How I Do It (and whyit’s best) (CC)Ballroom C

Coordinator: Robert J. Min, MD, FSIR

This categorical course will focus on state-of-the-art management of superficial venous insuffi-ciency. A panel of experts will present cases andcurrent approaches will be discussed and debated.Topics to be covered in the diagnosis and treat-ment of venous reflux include:

1. Is duplex ultrasound sufficient or is there a rolefor fluoroscopy?

2. How do we decide which veins need treatment?3. Is there a single “best” treatment for saphenous

vein reflux, i.e. surgery, endovenous laser, ra-diofrequency, or chemical ablation?

4. Ambulatory phlebectomy vs. sclerotherapy forlarge varicose veins following endovenous ab-lation: Which is better?

5. Is timing of adjunctive procedures important?6. When and how do we treat incompetent perfo-

rators?7. Leg telangiectasias: is sclerotherapy always best

or do surface lasers have a role?

Objectives—At the end of this session, thelearner should be able to:

1. Explain the role of duplex ultrasound in themanagement of venous insufficiency, includingpotential limitations

2. Discuss the current options available for treat-ment of varicose and spider veins

3. Demonstrate ways to refine current treatmentapproaches in order to improve outcomes

1:30 pmSaphenous Reflux: Endovenous LaserCarl M. Black, MD

1:40 pmSaphenous Reflux: RadiofrequencyMelvin Rosenblatt, MD

1:50 pmLeg Telangiectasia: Surface LaserSanjoy Kundu, MD

2:00 pmLeg Telangiectasia: SclerotherapyR. Torrance Andrews, MD, FSIR

2:10 pmPerforator Reflux: UGSChieh-Min Fan, MD

2:20 pmPerforator Reflux: Endovenous ThermalRobert J. Min, MD, FSIR

2:30 pmPudendal Varices: Sclerotherapy FirstNeil M. Khilnani, MD

2:40 pmPudendal Varices: Routine w/u for OvarianRefluxKeith M. Sterling, MD

2:50 pmPost-thrombotic Syndrome: CompressionSanjoy Kundu, MD

3:00 pmPost-thrombotic Syndrome: EndovascularSuresh Vedantham, MD

3:10 pmLiquid vs. Foam: FoamRobert L. Worthington-Kirsch, MD, FSIR

3:20 pmLiquid vs. Foam: LiquidRobert J. Min, MD, FSIR

1:30 pm–3:30 pmDevices Seminar: Oncologic Ablation (CC)Room: 207B

Coordinator: Jeanne M. LaBerge, MD, FSIR & JonathanSusman, MD

The practice of interventional radiology today re-quires that practitioners use a wide variety of med-ical devices in a number of different clinical set-tings. Understanding and mastering the use of allavailable devices is a daunting task. The IR Devices

P6

Seminar series is designed to organize informationabout the medical devices used in interventionalradiology in a way that makes the material morereadily accessible and understandable.

In this course, we will describe and categorize thecommon tools used for oncologic tissue ablation.Key characteristics of ablation devices will be re-viewed and features suitable to specific clinical ortechnical situations will be presented.

Objectives—At the end of this session, thelearner should be able to:

1. Classify the types of thermal energy sourcesused for oncologic ablation

2. Describe the operational features of a typicalradiofrequency ablation system

3. Explain how RF probe design influences proce-dural technique

4. Describe the operational features of cryoabla-tion systems

5. Identify emerging modalities for oncologic tis-sue ablation

1:30 pmIntroduction to the Device SeminarsJeanne M. LaBerge, MD, FSIR

1:30 pmTechnical Considerations of Device SelectionChristopher L. Brace, PhD

1:42 pmRFA: RITA/AngiodynamicsAllan Siperstein, MD

1:54 pmRFA: Radiotherapeutics/Boston ScientificJonathan Susman, MD

2:06 pmRFA: Internally Cooled ElectrodesS. Nahum Goldberg, MD, FSIR

2:18 pmAblation Augmentation: Combining TherapiesSteven C. Rose, MD, FSIR

2:30 pmMicrowaveDamian Dupuy, MD

2:42 pmIrreversible ElectroporationStephen T. Kee, MD

2:54 pmHIFUDavid Gianfelice

3:06 pmCryoablationPeter Littrup, MD

3:18 pmStereotactic Radiation & Cyberknife: Role of IRJoseph Herman, MD, MSC

1:30 pm–3:30 pmCase-based Review: Embolization (CC)Ballroom AB

Coordinator: Michael D. Darcy, MD, FSIR

This year at the Annual Meeting we will initiate aCase-based Review (CBR) series of eight topic-oriented categorical courses. These 2-hour sessionswill cover a broad range of material from VascularDiagnosis to Venous and Arterial Vascular Inter-ventions. In each session, three or four expertfaculty will present three or four cases each (for atotal of 10-12 unknowns) that illustrate the fullrange of interventions in that topic area. Facultywill present cases that challenge the diagnosticacumen or technical and medical knowledge of thelearner. A handout will be prepared for eachcourse that summarizes the important learningpoints of each case and provides references forfurther reading.

Based on the specific topic, at the end of thesession the learner should be able to:

1. Identify key diagnostic imaging findings of se-lected vascular pathologic conditions

2. List appropriate patient selection factors for ar-terial and venous vascular interventions

3. Describe expected complications of vascularand non-vascular interventions

4. Illustrate simple and complex treatment strate-gies for arterial and venous diseases

5. Relate key technical aspects of vascular andnon-vascular interventional procedures

1:30 pmCases 1-3Daniel B. Brown, MD

2:00 pmCases 4-6Jafar Golzarian, MD

2:30 pmCases 7-9Michael D. Darcy, MD, FSIR

3:00 pmCases 10-12Michael J. Wallace, MD, FSIR

SUNDAY

P7

4:00–6:00 pmIR Leadership–Options and Opportunities2008 (PL)Ballroom AB

Coordinators: James F. Benenati, MD, FSIR

This session will highlight the most important is-sues facing interventional radiology today. Mem-bers of the IR leadership will identify areas wherestrategic or tactical decisions need to be madewithin the IR community, present options and sug-gest the way forward. This session will address thebig issues of the day confronting IR—education,training, certification, practice improvement, re-search, and economics. The strategic plan of theSIR organization will be presented. The session isopen to all registrants and is meant to provide theIR community with a vision of the future of IR.

The President’s Address will be delivered duringthis session and Gold Medals of the Society will beawarded at the conclusion. The Opening Recep-tion will be held directly following this PlenarySession.

Objectives—At the end of this session, thelearner should be able to:

1. Identify the value of research and clinical trialsand how this strengthens the SIR as an organi-zation

2. Describe how procedural data can be collectedand the value of a national database

3. Have an understanding of the changes occur-ring with surgical billing codes and componentcoding and how it may affect the future of IR

4. Have insight into the benefits and risks of a solopractice in IR

5. Understand how to evaluate an IR practice froman economic perspective

6. Understand the changing landscape in treatingPAD and how IR is viewed in the eyes of otherspecialists and with industry

7. Understand the needs of those practicing IOand how the Society may support this initiative

8. Be familiar with educational trends in IR and theneed for MOC and how it affects IR

4:00 pmIntroductionJames F. Benenati, MD, FSIR

4:02 pmPAD Interventions in 2008: Who is doing them,Where Does IR fit in and What’s Going on in theSIRTimothy P. Murphy, MD, FSIR

4:10 pmShould IO split from the SIR? Pro: Let’s get a newhomeJeff H. Geschwind, MD, FSIR

4:15 pmShould IO split from the SIR? Con: IO’s home isThe SIRDaniel B. Brown, MD

4:20 pmEconomics of a successful IR Practice: How topay for ourselves, consults, imaging andphysician ExtendersHoward B. Chrisman, MD, MBA, FSIR

4:28 pmIndependent IR Practice: Is this a viable option?John C. Lipman, MD, FSIR

4:36 pmPartnering with Surgeons: Lessons LearnedRodney D. Raabe, MD, FSIR

4:42 pmWhat is on the Billing Horizon? Is ComponentBilling on the way out and what can we expectin the future?Michael E. Edwards, MD, FSIR

4:50 pmData Drives Decisions for Better or Worse: TheCase for Improved IT Support for Image GuidedInterventionsGary S. Dorfman, MD, FSIR

4:58 pmTraining IR’s in Conventional andUnconventional Pathways: Opening Doors andBuilding numbersWilliam S. Rilling, MD, FSIR

5:06 pmResearch, Investigation and Trials: SIR’s FutureJames B. Spies, MD, FSIR

5:14 pmJVIR: How does this Journal stack up to others?Albert A. Nemcek Jr., MD, FSIR

5:22 pmShould SIR open its membership to all specialties?Brian F. Stainken, MD, FSIR

P8